IL131129A - An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain - Google Patents

An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain

Info

Publication number
IL131129A
IL131129A IL13112998A IL13112998A IL131129A IL 131129 A IL131129 A IL 131129A IL 13112998 A IL13112998 A IL 13112998A IL 13112998 A IL13112998 A IL 13112998A IL 131129 A IL131129 A IL 131129A
Authority
IL
Israel
Prior art keywords
oral preparation
preparation according
astaxanthin
helicobacter
infection
Prior art date
Application number
IL13112998A
Other languages
English (en)
Hebrew (he)
Other versions
IL131129A0 (en
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of IL131129A0 publication Critical patent/IL131129A0/xx
Publication of IL131129A publication Critical patent/IL131129A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
IL13112998A 1997-02-27 1998-02-05 An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain IL131129A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
PCT/EP1998/000628 WO1998037874A1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection

Publications (2)

Publication Number Publication Date
IL131129A0 IL131129A0 (en) 2001-01-28
IL131129A true IL131129A (en) 2004-06-20

Family

ID=20405957

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13112998A IL131129A (en) 1997-02-27 1998-02-05 An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain

Country Status (15)

Country Link
US (1) US6262316B1 (ja)
EP (1) EP0981338B1 (ja)
JP (3) JP4267076B2 (ja)
KR (1) KR100569908B1 (ja)
CN (1) CN1119994C (ja)
AT (1) ATE243030T1 (ja)
AU (1) AU719090B2 (ja)
CA (1) CA2280715C (ja)
DE (1) DE69815677D1 (ja)
IL (1) IL131129A (ja)
NO (1) NO327303B1 (ja)
NZ (1) NZ337080A (ja)
PL (1) PL335370A1 (ja)
SE (1) SE522246C2 (ja)
WO (1) WO1998037874A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE524337C2 (sv) * 1998-10-16 2004-07-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
SE0001071D0 (sv) * 2000-03-27 2000-03-27 Astacarotene Ab Method of inhibiting the expression of inflammatory cytokines and chemokines
US7078040B2 (en) 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
KR100481880B1 (ko) * 2001-12-05 2005-04-11 (주)바이오벤 목이버섯으로부터 헬리코박터 파이로리의 부착억제성분을추출하는 방법 및 그 헬리코박터 파이로리의 부착억제성분
CA2473698A1 (en) * 2002-01-16 2003-07-31 Natural Alternatives International, Inc. Anti-inflammatory formulations
WO2004021798A1 (es) * 2002-09-03 2004-03-18 Centro De Investigacion En Alimentacion Y Desarrollo A.C. Metodo de preparacion de microcapsulas de astaxantina en quitosano y producto obtenido
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
GB0314624D0 (en) 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
JP4933097B2 (ja) * 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
WO2005102356A1 (en) 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CN1324989C (zh) * 2005-10-10 2007-07-11 华南理工大学 含虾青素营养食品及其制备方法
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5497372B2 (ja) * 2009-08-19 2014-05-21 バイオジェニック株式会社 非ステロイド性抗炎症薬起因性潰瘍の予防・治療薬
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
CN107691751A (zh) * 2017-11-12 2018-02-16 张雅萍 一种美容、香体的虾青素夹心凝胶糖果及其制备方法
US11065269B1 (en) * 2018-11-15 2021-07-20 Samuel L. Shepherd Method of using astaxanthin for the treatment of diseases, and more particularly, the treatment of cancer
CN114732130B (zh) * 2022-04-07 2024-01-23 云南雨藻生物科技有限公司 含雨生红球藻且抑制胃粘膜受损的组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0799924A (ja) 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH07300421A (ja) 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
WO1996023489A2 (de) * 1995-02-03 1996-08-08 Basf Aktiengesellschaft Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物

Also Published As

Publication number Publication date
AU6295198A (en) 1998-09-18
KR100569908B1 (ko) 2006-04-10
US6262316B1 (en) 2001-07-17
CN1119994C (zh) 2003-09-03
JP4463773B2 (ja) 2010-05-19
EP0981338A1 (en) 2000-03-01
IL131129A0 (en) 2001-01-28
KR20000070973A (ko) 2000-11-25
NO327303B1 (no) 2009-06-02
PL335370A1 (en) 2000-04-25
NO994109L (no) 1999-10-27
NZ337080A (en) 2001-03-30
JP2006188526A (ja) 2006-07-20
JP4267076B2 (ja) 2009-05-27
ATE243030T1 (de) 2003-07-15
CA2280715A1 (en) 1998-09-03
JP2001517213A (ja) 2001-10-02
SE522246C2 (sv) 2004-01-27
DE69815677D1 (de) 2003-07-24
SE9700708L (sv) 1998-08-28
SE9700708D0 (sv) 1997-02-27
WO1998037874A1 (en) 1998-09-03
EP0981338B1 (en) 2003-06-18
AU719090B2 (en) 2000-05-04
CN1248912A (zh) 2000-03-29
NO994109D0 (no) 1999-08-25
CA2280715C (en) 2008-10-07
JP2010111689A (ja) 2010-05-20

Similar Documents

Publication Publication Date Title
JP4463773B2 (ja) Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
US8853269B2 (en) Composition and method for treating infections and promoting intestinal health
JP5400997B2 (ja) 哺乳動物の大腸内のガス発生及びこれに起因する腹部症状を回避又は低減するための、鉱物質及び場合によっては酢酸生成菌及び／又は酪酸生成菌からなる組成物の使用
ES2967899T3 (es) Bioconversión de oleuropeína
Zhang et al. Dietary genistein supplementation improves intestinal mucosal barrier function in Escherichia coli O78-challenged broilers
US20230190824A1 (en) Bacterium of the christensenellaceae family in the prevention and/or treatment of hypertriglyceridemia
Kang et al. Efficacy of polymers from spontaneous carotenoid oxidation in reducing necrotic enteritis in broilers
ES2925635T3 (es) Bioconversión de oleuropeína
AU763995B2 (en) Treatment of dyspepsia
KR101160743B1 (ko) 녹차를 유효성분으로 함유하는 조류 인플루엔자에 대한 항바이러스제
KR20150091715A (ko) 감마-리놀렌산을 포함하는 결핵의 치료 및 예방용 항결핵 조성물
AU2011270971B2 (en) Composition and method of treating lipid encapsulated virus infections
WO2020079641A1 (en) Compositions comprising essential oils and/or hydrolates from plants of italian origin and the use thereof for the treatment of gastrointestinal and genitourinary disorders
IT202000032402A1 (it) Composizione immunostimolante per indurre una risposta immunitaria

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees